Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mismatch repair deficiency is rare in bone and soft tissue tumors.
Lam SW, Kostine M, de Miranda NFCC, Schöffski P, Lee CJ, Morreau H, Bovée JVMG. Lam SW, et al. Among authors: lee cj. Histopathology. 2021 Oct;79(4):509-520. doi: 10.1111/his.14377. Epub 2021 Jun 8. Histopathology. 2021. PMID: 33825202 Free PMC article.
Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE.
Schöffski P, Kubickova M, Wozniak A, Blay JY, Strauss SJ, Stacchiotti S, Switaj T, Bücklein V, Leahy MG, Italiano A, Isambert N, Debiec-Rychter M, Sciot R, Lee CJ, Speetjens FM, Nzokirantevye A, Neven A, Kasper B. Schöffski P, et al. Among authors: lee cj. Eur J Cancer. 2021 Oct;156:12-23. doi: 10.1016/j.ejca.2021.07.016. Epub 2021 Aug 13. Eur J Cancer. 2021. PMID: 34392187 Free article. Clinical Trial.
Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib.
Lee CJ, Schöffski P, Modave E, van Wezel T, Boeckx B, Sufliarsky J, Gelderblom H, Blay JY, Debiec-Rychter M, Sciot R, Bovée JVMG, Lambrechts D, Wozniak A. Lee CJ, et al. Clin Cancer Res. 2021 Dec 15;27(24):6737-6748. doi: 10.1158/1078-0432.CCR-21-1165. Epub 2021 Sep 22. Clin Cancer Res. 2021. PMID: 34551905
Machine learning for rhabdomyosarcoma histopathology.
Frankel AO, Lathara M, Shaw CY, Wogmon O, Jackson JM, Clark MM, Eshraghi N, Keenen SE, Woods AD, Purohit R, Ishi Y, Moran N, Eguchi M, Ahmed FUA, Khan S, Ioannou M, Perivoliotis K, Li P, Zhou H, Alkhaledi A, Davis EJ, Galipeau D, Randall RL, Wozniak A, Schoffski P, Lee CJ, Huang PH, Jones RL, Rubin BP, Darrow M, Srinivasa G, Rudzinski ER, Chen S, Berlow NE, Keller C. Frankel AO, et al. Among authors: lee cj. Mod Pathol. 2022 Sep;35(9):1193-1203. doi: 10.1038/s41379-022-01075-x. Epub 2022 Apr 21. Mod Pathol. 2022. PMID: 35449398 Free article.
Enhanced Antitumor Efficacy of PhAc-ALGP-Dox, an Enzyme-Activated Doxorubicin Prodrug, in a Panel of THOP1-Expressing Patient-Derived Xenografts of Soft Tissue Sarcoma.
Van Renterghem B, Wozniak A, Tarantola L, Casazza A, Wellens J, Nysen M, Vanleeuw U, Lee CJ, Reyns G, Sciot R, Kindt N, Schöffski P. Van Renterghem B, et al. Among authors: lee cj. Biomedicines. 2022 Apr 6;10(4):862. doi: 10.3390/biomedicines10040862. Biomedicines. 2022. PMID: 35453612 Free PMC article.
Correction to: Machine learning for rhabdomyosarcoma histopathology.
Frankel AO, Lathara M, Shaw CY, Wogmon O, Jackson JM, Clark MM, Eshraghi N, Keenen SE, Woods AD, Purohit R, Ishi Y, Moran N, Eguchi M, Ahmed FUA, Khan S, Ioannou M, Perivoliotis K, Li P, Zhou H, Alkhaledi A, Davis EJ, Galipeau D, Randall RL, Wozniak A, Schoffski P, Lee CJ, Huang PH, Jones RL, Rubin BP, Darrow M, Srinivasa G, Rudzinski ER, Chen S, Berlow NE, Keller C. Frankel AO, et al. Among authors: lee cj. Mod Pathol. 2022 Oct;35(10):1496. doi: 10.1038/s41379-022-01098-4. Mod Pathol. 2022. PMID: 35578013 Free article. No abstract available.
Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial.
Lee CJ, Modave E, Boeckx B, Kasper B, Aamdal S, Leahy MG, Rutkowski P, Bauer S, Debiec-Rychter M, Sciot R, Lambrechts D, Wozniak A, Schöffski P. Lee CJ, et al. Int J Mol Sci. 2022 May 19;23(10):5689. doi: 10.3390/ijms23105689. Int J Mol Sci. 2022. PMID: 35628499 Free PMC article.
2,152 results